Fsd Pharma Class Stock Alpha and Beta Analysis
| HUGE Stock | USD 0.41 0.03 6.82% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as FSD Pharma Class. It also helps investors analyze the systematic and unsystematic risks associated with investing in FSD Pharma over a specified time horizon. Remember, high FSD Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to FSD Pharma's market risk premium analysis include:
Beta 2.14 | Alpha (0.97) | Risk 4.34 | Sharpe Ratio (0.21) | Expected Return (0.93) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
FSD |
FSD Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. FSD Pharma market risk premium is the additional return an investor will receive from holding FSD Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in FSD Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate FSD Pharma's performance over market.| α | -0.97 | β | 2.14 |
FSD Pharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of FSD Pharma's Buy-and-hold return. Our buy-and-hold chart shows how FSD Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.FSD Pharma Market Price Analysis
Market price analysis indicators help investors to evaluate how FSD Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading FSD Pharma shares will generate the highest return on investment. By understating and applying FSD Pharma stock market price indicators, traders can identify FSD Pharma position entry and exit signals to maximize returns.
FSD Pharma Return and Market Media
The median price of FSD Pharma for the period between Thu, Feb 1, 2024 and Wed, May 1, 2024 is 0.76 with a coefficient of variation of 20.75. The daily time series for the period is distributed with a sample standard deviation of 0.15, arithmetic mean of 0.74, and mean deviation of 0.13. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | FSD Pharma Inc Partners with H.C. Wainwright in a Strategic At-the-Market Offering to Propel Research and Development - BNN Breaking | 02/20/2024 |
2 | FSD Pharmas Stake In Functional Beverage, UNBUZZD, Is A Transformational AssetHeres Why - News Channel Nebraska | 03/12/2024 |
3 | FSD Pharma GAAP EPS of -0.46 | 04/02/2024 |
4 | FSD Pharma receives Nasdaq notification regarding minimum bid price deficiency - MSN | 04/08/2024 |
5 | FSD Pharma stock gains on unbuzzd tie-up | 04/25/2024 |
About FSD Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including FSD or other stocks. Alpha measures the amount that position in FSD Pharma Class has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 (projected) | Payables Turnover | 1.58 | 0.79 | 0.86 | Days Of Inventory On Hand | 0.018 | 2.86E-4 | 2.72E-4 |
FSD Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of FSD Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, FSD Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of FSD Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of FSD Pharma. Please utilize our Beneish M Score to check the likelihood of FSD Pharma's management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with FSD Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out FSD Pharma Backtesting, FSD Pharma Valuation, FSD Pharma Correlation, FSD Pharma Hype Analysis, FSD Pharma Volatility, FSD Pharma History and analyze FSD Pharma Performance. Note that the FSD Pharma Class information on this page should be used as a complementary analysis to other FSD Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for FSD Stock analysis
When running FSD Pharma's price analysis, check to measure FSD Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FSD Pharma is operating at the current time. Most of FSD Pharma's value examination focuses on studying past and present price action to predict the probability of FSD Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FSD Pharma's price. Additionally, you may evaluate how the addition of FSD Pharma to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
FSD Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.